| Central Minnesota Dementia Community Action Network | |
|
3701 12th St N Ste 103 Saint Cloud MN 56303-2253 | |
| (320) 640-6726 | |
| (320) 774-1238 |
| Full Name | Central Minnesota Dementia Community Action Network |
|---|---|
| Speciality | Family Medicine |
| Location | 3701 12th St N Ste 103, Saint Cloud, Minnesota |
| Authorized Official Name and Position | Patrick Joseph Zook (PRESIDENT) |
| Authorized Official Contact | 3204928207 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Central Minnesota Dementia Community Action Network 7447 River Bend Ct Sauk Rapids MN 56379-9327 Ph: (320) 492-8207 | Central Minnesota Dementia Community Action Network 3701 12th St N Ste 103 Saint Cloud MN 56303-2253 Ph: (320) 640-6726 |
| NPI Number | 1538826771 |
|---|---|
| Provider Enumeration Date | 11/22/2021 |
| Last Update Date | 11/22/2021 |
| Medicare PECOS PAC ID | 1456747666 |
|---|---|
| Medicare Enrollment ID | O20220414001504 |
News Archive
Antibiotic resistance in the natural environment is rising despite tighter controls over our use of antibiotics in medicine and agriculture, Newcastle University scientists have found.
Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON® (pancrelipase) Delayed-Release Capsules to treat exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF). The CREON 3,000 units of lipase capsule provides the lowest dosage strength in the class approved by the FDA. This new option will enable more precise dosing titration in accordance with the Cystic Fibrosis Foundation guidelines for infant dosing.
Small Bone Innovations, an orthopedics company focused exclusively on serving patients and their physicians with technologies and treatments for joint repair and trauma reconstruction around the small bones & joints of the thumb, fingers, hand, wrist, elbow, toes and foot & ankle announced that it has received 510(k) pre-market clearance notification from the U.S. Food and Drug Administration for the radial Head Extended Stem to be used in the correction of complex elbow instabilities and/or elbow reconstruction.
A large international study has linked early puberty and childlessness with an increased risk of early menopause.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538826771 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Patrick Joseph Zook |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1891730115 PECOS PAC ID: 6608851498 Enrollment ID: I20080228000701 |
News Archive
Antibiotic resistance in the natural environment is rising despite tighter controls over our use of antibiotics in medicine and agriculture, Newcastle University scientists have found.
Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON® (pancrelipase) Delayed-Release Capsules to treat exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF). The CREON 3,000 units of lipase capsule provides the lowest dosage strength in the class approved by the FDA. This new option will enable more precise dosing titration in accordance with the Cystic Fibrosis Foundation guidelines for infant dosing.
Small Bone Innovations, an orthopedics company focused exclusively on serving patients and their physicians with technologies and treatments for joint repair and trauma reconstruction around the small bones & joints of the thumb, fingers, hand, wrist, elbow, toes and foot & ankle announced that it has received 510(k) pre-market clearance notification from the U.S. Food and Drug Administration for the radial Head Extended Stem to be used in the correction of complex elbow instabilities and/or elbow reconstruction.
A large international study has linked early puberty and childlessness with an increased risk of early menopause.
› Verified 7 days ago
| Provider Name | Katrina V Sand |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1801384078 PECOS PAC ID: 9436406840 Enrollment ID: I20180717001046 |
News Archive
Antibiotic resistance in the natural environment is rising despite tighter controls over our use of antibiotics in medicine and agriculture, Newcastle University scientists have found.
Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON® (pancrelipase) Delayed-Release Capsules to treat exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF). The CREON 3,000 units of lipase capsule provides the lowest dosage strength in the class approved by the FDA. This new option will enable more precise dosing titration in accordance with the Cystic Fibrosis Foundation guidelines for infant dosing.
Small Bone Innovations, an orthopedics company focused exclusively on serving patients and their physicians with technologies and treatments for joint repair and trauma reconstruction around the small bones & joints of the thumb, fingers, hand, wrist, elbow, toes and foot & ankle announced that it has received 510(k) pre-market clearance notification from the U.S. Food and Drug Administration for the radial Head Extended Stem to be used in the correction of complex elbow instabilities and/or elbow reconstruction.
A large international study has linked early puberty and childlessness with an increased risk of early menopause.
› Verified 7 days ago
| Provider Name | Sara R Devos |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1417388794 PECOS PAC ID: 2365815206 Enrollment ID: I20230227000061 |
News Archive
Antibiotic resistance in the natural environment is rising despite tighter controls over our use of antibiotics in medicine and agriculture, Newcastle University scientists have found.
Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON® (pancrelipase) Delayed-Release Capsules to treat exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF). The CREON 3,000 units of lipase capsule provides the lowest dosage strength in the class approved by the FDA. This new option will enable more precise dosing titration in accordance with the Cystic Fibrosis Foundation guidelines for infant dosing.
Small Bone Innovations, an orthopedics company focused exclusively on serving patients and their physicians with technologies and treatments for joint repair and trauma reconstruction around the small bones & joints of the thumb, fingers, hand, wrist, elbow, toes and foot & ankle announced that it has received 510(k) pre-market clearance notification from the U.S. Food and Drug Administration for the radial Head Extended Stem to be used in the correction of complex elbow instabilities and/or elbow reconstruction.
A large international study has linked early puberty and childlessness with an increased risk of early menopause.
› Verified 7 days ago
News Archive
Antibiotic resistance in the natural environment is rising despite tighter controls over our use of antibiotics in medicine and agriculture, Newcastle University scientists have found.
Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON® (pancrelipase) Delayed-Release Capsules to treat exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF). The CREON 3,000 units of lipase capsule provides the lowest dosage strength in the class approved by the FDA. This new option will enable more precise dosing titration in accordance with the Cystic Fibrosis Foundation guidelines for infant dosing.
Small Bone Innovations, an orthopedics company focused exclusively on serving patients and their physicians with technologies and treatments for joint repair and trauma reconstruction around the small bones & joints of the thumb, fingers, hand, wrist, elbow, toes and foot & ankle announced that it has received 510(k) pre-market clearance notification from the U.S. Food and Drug Administration for the radial Head Extended Stem to be used in the correction of complex elbow instabilities and/or elbow reconstruction.
A large international study has linked early puberty and childlessness with an increased risk of early menopause.
› Verified 7 days ago
Centracare - Coordinated Care Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2025 Stearns Way Ste 114, Saint Cloud, MN 56303 Phone: 320-255-7195 Fax: 320-200-3245 | |
St. Cloud State University Medical Clinic And Pharmacy Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 720 4th Ave S, Saint Cloud, MN 56301 Phone: 320-308-3193 Fax: 320-308-3192 | |
Centracare Health Community Paramedic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1406 6th Ave N, Saint Cloud, MN 56303 Phone: 320-251-2700 Fax: 320-255-5711 | |
Midsota Plastic & Reconstructive Surgeons Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3701 12th St N, Suite 100, Saint Cloud, MN 56303 Phone: 320-253-7257 Fax: 320-257-5671 | |
Memory Care Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2835 W Saint Germain St, Saint Cloud, MN 56301 Phone: 320-257-1777 Fax: 320-257-1776 | |
Center For Life Transitions Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 38 24th Ave N, Saint Cloud, MN 56303 Phone: 320-746-0025 | |
Core Philosophy Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 510 25th Ave N Ste B1-114, Saint Cloud, MN 56303 Phone: 612-703-5479 |